{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:28:40Z","timestamp":1707524920832},"reference-count":28,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,3,1]]},"DOI":"10.7759\/cureus.35629","type":"journal-article","created":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T08:13:05Z","timestamp":1677658385000},"source":"Crossref","is-referenced-by-count":0,"title":["The Outcome of COVID-19 Infection in Patients With Gastrointestinal Diseases: An Experience at a Tertiary Center"],"prefix":"10.7759","author":[{"given":"Irgen","family":"Tafaj","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liri","family":"Cuko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qazim","family":"\u00c7ili","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arlinda","family":"Hysenj","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edite","family":"Sadiku","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2001017","article-title":"A novel coronavirus from patients with pneumonia in China, 2019","volume":"382","author":"Zhu N","year":"2020","unstructured":"Zhu N, Zhang D, Wang W, et al.. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020, 382:727-33. 10.1056\/NEJMoa2001017","journal-title":"N Engl J Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-020-0968-3","article-title":"Extrapulmonary manifestations of COVID-19","volume":"26","author":"Gupta A","year":"2020","unstructured":"Gupta A, Madhavan MV, Sehgal K, et al.. Extrapulmonary manifestations of COVID-19. Nat Med. 2020, 26:1017-32. 10.1038\/s41591-020-0968-3","journal-title":"Nat Med"},{"key":"ref3","article-title":"Daily report on COVID-19","author":"Albanian Institute of Public Health","year":"2023","unstructured":"Albanian Institute of Public Health. Daily report on COVID-19. Albanian Institute of Public Health. 2023,","journal-title":"Albanian Institute of Public Health"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2020.02.055","article-title":"Evidence for gastrointestinal infection of SARS-CoV-2","volume":"158","author":"Xiao F","year":"2020","unstructured":"Xiao F, Tang M, Zheng X, Liu Y, Li X, Shan H. Evidence for gastrointestinal infection of SARS-CoV-2. Gastroenterology. 2020, 158:1831-1833.e3. 10.1053\/j.gastro.2020.02.055","journal-title":"Gastroenterology"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1002\/path.5471","article-title":"Angiotensin-converting enzyme 2 (ACE2), SARS-CoV-2 and the pathophysiology of coronavirus disease 2019 (COVID-19)","volume":"251","author":"Bourgonje AR","year":"2020","unstructured":"Bourgonje AR, Abdulle AE, Timens W, et al.. Angiotensin-converting enzyme 2 (ACE2), SARS-CoV-2 and the pathophysiology of coronavirus disease 2019 (COVID-19). J Pathol. 2020, 251:228-48. 10.1002\/path.5471","journal-title":"J Pathol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2020.05.030","article-title":"Age, inflammation, and disease location are critical determinants of intestinal expression of SARS-CoV-2 receptor ACE2 and TMPRSS2 in inflammatory bowel disease","volume":"159","author":"Nowak JK","year":"2020","unstructured":"Nowak JK, Lindstr\u00f8m JC, Kalla R, Ricanek P, Halfvarson J, Satsangi J. Age, inflammation, and disease location are critical determinants of intestinal expression of SARS-CoV-2 receptor ACE2 and TMPRSS2 in inflammatory bowel disease. Gastroenterology. 2020, 159:1151-1154.e2. 10.1053\/j.gastro.2020.05.030","journal-title":"Gastroenterology"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1038\/nri.2016.90","article-title":"Sex differences in immune responses","volume":"16","author":"Klein SL","year":"2016","unstructured":"Klein SL, Flanagan KL. Sex differences in immune responses. Nat Rev Immunol. 2016, 16:626-38. 10.1038\/nri.2016.90","journal-title":"Nat Rev Immunol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbi.2016.08.002","article-title":"Age and sex differences in immune response following LPS treatment in mice","volume":"58","author":"Cai KC","year":"2016","unstructured":"Cai KC, van Mil S, Murray E, Mallet JF, Matar C, Ismail N. Age and sex differences in immune response following LPS treatment in mice. Brain Behav Immun. 2016, 58:327-37. 10.1016\/j.bbi.2016.08.002","journal-title":"Brain Behav Immun"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1007\/s15010-015-0791-9","article-title":"Sex differences in immune responses to infectious diseases","volume":"43","author":"Fischer J","year":"2015","unstructured":"Fischer J, Jung N, Robinson N, Lehmann C. Sex differences in immune responses to infectious diseases. Infection. 2015, 43:399-403. 10.1007\/s15010-015-0791-9","journal-title":"Infection"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofaa638","article-title":"Risk of clinical severity by age and race\/ethnicity among adults hospitalized for COVID-19-United States, March-September 2020","volume":"8","author":"Pennington AF","year":"2021","unstructured":"Pennington AF, Kompaniyets L, Summers AD, et al.. Risk of clinical severity by age and race\/ethnicity among adults hospitalized for COVID-19-United States, March-September 2020. Open Forum Infect Dis. 2021, 8:ofaa638. 10.1093\/ofid\/ofaa638","journal-title":"Open Forum Infect Dis"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.890517","article-title":"COVID-19 and preexisting comorbidities: risks, synergies, and clinical outcomes","volume":"13","author":"Bigdelou B","year":"2022","unstructured":"Bigdelou B, Sepand MR, Najafikhoshnoo S, et al.. COVID-19 and preexisting comorbidities: risks, synergies, and clinical outcomes. Front Immunol. 2022, 13:890517. 10.3389\/fimmu.2022.890517","journal-title":"Front Immunol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor","volume":"181","author":"Hoffmann M","year":"2020","unstructured":"Hoffmann M, Kleine-Weber H, Schroeder S, et al.. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 2020, 181:271-280.e8. 10.1016\/j.cell.2020.02.052","journal-title":"Cell"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2014.08.010","article-title":"Cirrhosis-associated immune dysfunction: distinctive features and clinical relevance","volume":"61","author":"Albillos A","year":"2014","unstructured":"Albillos A, Lario M, \u00c1lvarez-Mon M. Cirrhosis-associated immune dysfunction: distinctive features and clinical relevance. J Hepatol. 2014, 61:1385-96. 10.1016\/j.jhep.2014.08.010","journal-title":"J Hepatol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2020.09.024","article-title":"Outcomes following SARS-CoV-2 infection in patients with chronic liver disease: an international registry study","volume":"74","author":"Marjot T","year":"2021","unstructured":"Marjot T, Moon AM, Cook JA, et al.. Outcomes following SARS-CoV-2 infection in patients with chronic liver disease: an international registry study. J Hepatol. 2021, 74:567-77. 10.1016\/j.jhep.2020.09.024","journal-title":"J Hepatol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1136\/bmjgast-2020-000417","article-title":"Novelty in the gut: a systematic review and meta-analysis of the gastrointestinal manifestations of COVID-19","volume":"7","author":"Suresh Kumar VC","year":"2020","unstructured":"Suresh Kumar VC, Mukherjee S, Harne PS, Subedi A, Ganapathy MK, Patthipati VS, Sapkota B. Novelty in the gut: a systematic review and meta-analysis of the gastrointestinal manifestations of COVID-19. BMJ Open Gastroenterol. 2020, 7:10.1136\/bmjgast-2020-000417","journal-title":"BMJ Open Gastroenterol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2020.05.001","article-title":"AGA institute rapid review of the gastrointestinal and liver manifestations of COVID-19, meta-analysis of international data, and recommendations for the consultative management of patients with COVID-19","volume":"159","author":"Sultan S","year":"2020","unstructured":"Sultan S, Altayar O, Siddique SM, et al.. AGA institute rapid review of the gastrointestinal and liver manifestations of COVID-19, meta-analysis of international data, and recommendations for the consultative management of patients with COVID-19. Gastroenterology. 2020, 159:320-334.e27. 10.1053\/j.gastro.2020.05.001","journal-title":"Gastroenterology"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1111\/apt.15813","article-title":"Review article: COVID-19 and liver disease-what we know on 1st May 2020","volume":"52","author":"Garrido I","year":"2020","unstructured":"Garrido I, Liberal R, Macedo G. Review article: COVID-19 and liver disease-what we know on 1st May 2020. Aliment Pharmacol Ther. 2020, 52:267-75. 10.1111\/apt.15813","journal-title":"Aliment Pharmacol Ther"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.cpcardiol.2019.04.002","article-title":"Reference values for neutrophil to lymphocyte ratio (NLR), a biomarker of cardiovascular risk, according to age and sex in a Latin American population","volume":"46","author":"Huguet E","year":"2021","unstructured":"Huguet E, Maccallini G, Pardini P, et al.. Reference values for neutrophil to lymphocyte ratio (NLR), a biomarker of cardiovascular risk, according to age and sex in a Latin American population. Curr Probl Cardiol. 2021, 46:100422. 10.1016\/j.cpcardiol.2019.04.002","journal-title":"Curr Probl Cardiol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.02456","article-title":"Understanding the multifaceted role of neutrophils in cancer and autoimmune diseases","volume":"9","author":"Wang X","year":"2018","unstructured":"Wang X, Qiu L, Li Z, Wang XY, Yi H. Understanding the multifaceted role of neutrophils in cancer and autoimmune diseases. Front Immunol. 2018, 9:2456. 10.3389\/fimmu.2018.02456","journal-title":"Front Immunol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-021-05796-3","article-title":"Predictive value of the neutrophil to lymphocyte ratio for disease deterioration and serious adverse outcomes in patients with COVID-19: a prospective cohort study","volume":"21","author":"Zeng ZY","year":"2021","unstructured":"Zeng ZY, Feng SD, Chen GP, Wu JN. Predictive value of the neutrophil to lymphocyte ratio for disease deterioration and serious adverse outcomes in patients with COVID-19: a prospective cohort study. BMC Infect Dis. 2021, 21:80. 10.1186\/s12879-021-05796-3","journal-title":"BMC Infect Dis"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajem.2020.11.058","article-title":"Neutrophil to lymphocyte ratio, lymphocyte to monocyte ratio and platelet to lymphocyte ratio to predict the severity of COVID-19","volume":"40","author":"Seyit M","year":"2021","unstructured":"Seyit M, Avci E, Nar R, et al.. Neutrophil to lymphocyte ratio, lymphocyte to monocyte ratio and platelet to lymphocyte ratio to predict the severity of COVID-19. Am J Emerg Med. 2021, 40:110-4. 10.1016\/j.ajem.2020.11.058","journal-title":"Am J Emerg Med"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2020.106504","article-title":"The diagnostic and predictive role of NLR, d-NLR and PLR in COVID-19 patients","volume":"84","author":"Yang AP","year":"2020","unstructured":"Yang AP, Liu JP, Tao WQ, Li HM. The diagnostic and predictive role of NLR, d-NLR and PLR in COVID-19 patients. Int Immunopharmacol. 2020, 84:106504. 10.1016\/j.intimp.2020.106504","journal-title":"Int Immunopharmacol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.3390\/molecules25235725","article-title":"The systemic inflammation index on admission predicts in-hospital mortality in COVID-19 patients","volume":"25","author":"Fois AG","year":"2020","unstructured":"Fois AG, Paliogiannis P, Scano V, et al.. The systemic inflammation index on admission predicts in-hospital mortality in COVID-19 patients. Molecules. 2020, 25:10.3390\/molecules25235725","journal-title":"Molecules"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1097\/SHK.0000000000001585","article-title":"Neutrophil-to-lymphocyte ratio and outcomes in Louisiana COVID-19 patients","volume":"54","author":"Tatum D","year":"2020","unstructured":"Tatum D, Taghavi S, Houghton A, Stover J, Toraih E, Duchesne J. Neutrophil-to-lymphocyte ratio and outcomes in Louisiana COVID-19 patients. Shock. 2020, 54:652-8. 10.1097\/SHK.0000000000001585","journal-title":"Shock"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-00927-x","article-title":"Prognostic value of neutrophil-to-lymphocyte ratio in COVID-19 compared with Influenza and respiratory syncytial virus infection","volume":"11","author":"Prozan L","year":"2021","unstructured":"Prozan L, Shusterman E, Ablin J, et al.. Prognostic value of neutrophil-to-lymphocyte ratio in COVID-19 compared with Influenza and respiratory syncytial virus infection. Sci Rep. 2021, 11:21519. 10.1038\/s41598-021-00927-x","journal-title":"Sci Rep"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1038\/nri.2017.10","article-title":"Neutrophils as protagonists and targets in chronic inflammation","volume":"17","author":"Soehnlein O","year":"2017","unstructured":"Soehnlein O, Steffens S, Hidalgo A, Weber C. Neutrophils as protagonists and targets in chronic inflammation. Nat Rev Immunol. 2017, 17:248-61. 10.1038\/nri.2017.10","journal-title":"Nat Rev Immunol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1172\/JCI137244","article-title":"Clinical and immunological features of severe and moderate coronavirus disease 2019","volume":"130","author":"Chen G","year":"2020","unstructured":"Chen G, Wu D, Guo W, et al.. Clinical and immunological features of severe and moderate coronavirus disease 2019. J Clin Invest. 2020, 130:2620-9. 10.1172\/JCI137244","journal-title":"J Clin Invest"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-022-06122-1","article-title":"Systemic inflammation response index (SIRI) as a novel biomarker in patients with rheumatoid arthritis: a multi-center retrospective study","volume":"41","author":"Xu Y","year":"2022","unstructured":"Xu Y, He H, Zang Y, et al.. Systemic inflammation response index (SIRI) as a novel biomarker in patients with rheumatoid arthritis: a multi-center retrospective study. Clin Rheumatol. 2022, 41:1989-2000. 10.1007\/s10067-022-06122-1","journal-title":"Clin Rheumatol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/140792-the-outcome-of-covid-19-infection-in-patients-with-gastrointestinal-diseases-an-experience-at-a-tertiary-center","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:59:56Z","timestamp":1707508796000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/140792-the-outcome-of-covid-19-infection-in-patients-with-gastrointestinal-diseases-an-experience-at-a-tertiary-center"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,1]]},"references-count":28,"URL":"https:\/\/doi.org\/10.7759\/cureus.35629","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3,1]]}}}